Manufacturing and Production

Showing 15 posts of 5857 posts found.

Regulatory assistance available to Small and Medium-sized Enterprises (SMEs)

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The increasing number of SMEs in Europe is seen to be a driving force to facilitate economic growth, new product …

Deadline approaching for cancelling UK Licences

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The MHRA has recently advised all holders of UK marketing authorisations, registrations and licences to inform them by the 31st …

Updated report on origins of clinical trial participants

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency has published an updated report detailing the geographical origins of patients included in clinical trials for …

Scientific Advice and Guidance Available

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In April, we reported how a joint pilot scheme operated by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), …

Savient plays down gout drug manufacturing problems

January 11, 2011 Manufacturing and Production, Sales and Marketing Krystexxa, Savient, biologic manufacturing, gout, manufacturing compliance, pegloticase

Savient Pharmaceuticals has reported that some production batches of Krystexxa, its recently-approved second-line treatment for gout, have failed to meet …

Dendreon will outsource first Provenge production in EU

January 11, 2011 Manufacturing and Production Dendreon, Provenge, cancer vaccine, contract manufacturing, sipuleucel-T, vaccine manufacturing, vaccines

US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …

More US recalls as bill seeks greater FDA powers

January 10, 2011 Manufacturing and Production Centocor Ortho Biotech, Cumberland Pharmaceuticals, FDA, RiteDose Corp, Sandoz, Sigma-tau Pharmasource, Teva Pharmaceuticals, manufacturing compliance, recalls

Product recalls continue to make headlines in the pharmaceutical sector, with several new incidents either side of the New Year …
GSK's UK headquarters

GSK hits back at 60 Minutes whistleblower interview

January 6, 2011 Manufacturing and Production 60 Minutes, Avandamet, Bactroban, Cheryl Eckard, GSK, GlaxoSmithKline, Kytril, Paxil, manufacturing compliance

GlaxoSmithKline has responded to an edition of US current affairs show 60 Minutes centring on manufacturing problems at its now-closed …
Novartis Holly Springs

Novartis adds R&D unit to new vaccines plant

December 31, 2010 Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines

Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …

UCB plans €250m plant to meet Cimzia demand

December 29, 2010 Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing

Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …

SHL Expands Range of Automation Solutions for Auto Injector Assembly

December 29, 2010 Manufacturing and Production assembly, auto injector, autoinjector, shl group

December 23, 2010 [Taoyuan, Taiwan]: With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under …

Pfizer expands Lipitor recall

December 24, 2010 Manufacturing and Production Lipitor, Pfizer, manufacturing compliance, recalls

Pfizer has been forced to recall another 19,000 bottles of its cholesterol-lowering drug Lipitor in the US after consumers reported …

2010: Pharma’s year in review

December 23, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review

2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …

Novartis makes $500m investment in Russia

December 21, 2010 Manufacturing and Production, Research and Development Novartis, Russia, pharma manufacturing

Novartis is planning to invest $500 million in Russia over the next five years, in a programme which will include …
The Gateway to Local Adoption Series

Latest content